Patient Centered Communication Training to Reduce Antibiotic Use in Acute Respiratory Tract Infections
Multidimensional Intervention Program to Reduce Antibiotic Prescriptions for Acute Respiratory Tract Infections in Adults: a Randomized Controlled Trial in Primary Care
4 other identifiers
interventional
900
1 country
1
Brief Summary
The purpose of this study is to evaluate the effectiveness of a short training program for general practitioners in patient-centered communication to reduce antibiotic prescription for acute respiratory tract infections (ARTI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2004
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2004
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2004
CompletedFirst Submitted
Initial submission to the registry
March 10, 2005
CompletedFirst Posted
Study publicly available on registry
March 11, 2005
CompletedMay 11, 2016
May 1, 2016
March 10, 2005
May 10, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Up-take of antibiotic prescription confirmed by pharmacists within 2 weeks following the initial consultation
Secondary Outcomes (6)
Patient satisfaction with consultation (on validated scale)
patient enablement (on validated scale)
days with restriction from ARTI within 14 days initial consultation
side effects from medication
re-consultation rates
- +1 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- years or older
- Symptoms of an acute respiratory tract infection for \>1 and \<28 days
You may not qualify if:
- Patients without informed consent
- Not fluent in German
- Patients with a psychiatric disorder
- Patients with a recurrent respiratory system infection with antibiotic treatment in the previous 4 weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Basel, Switzerlandlead
- Basel Institute of Clinical Epidemiology (BICE)collaborator
- Swiss National Science Foundationcollaborator
- Novartiscollaborator
Study Sites (1)
Basel institute for clinical epidemiology
Basel, 4031, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heiner Bucher, Prof.
University Hospital, Basel, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2005
First Posted
March 11, 2005
Study Start
January 1, 2004
Study Completion
June 1, 2004
Last Updated
May 11, 2016
Record last verified: 2016-05